U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07024550) titled 'rTMS Impact on the Brain Reward Pathway' on June 09.
Brief Summary: The goal of this clinical trial is to thoroughly explore and ascertain the mechanism of action of the therapy with the BTL-699-2 device in the treatment of food cravings (serving as an important precipitant to binge eating episodes), among binge eaters and to confirm its efficacy and safety, in adult binge-eating patients with food cravings. The main question it aims to answer is:
To ascertain the mechanism of action of the treatment with a BTL-699-2 device equipped with a BTL-699-AP-M-2 applicator in reducing food cravings, for the active group only.
Participants...